Additionally, evidence has emerged indicating that IL-33 might influence breast cancer metabolism, especially by elevating Lipin-1 (LPIN-1) expression, a molecule involved in phospholipid metabolism [61,62]. This evidence concerns the gene LPIN1 and breast cancer.